[PDF] Top 20 Actividad física y composición corporal en escolares aragoneses

... The use of rescue medication differed according to the duration of chemotherapy ...In chemotherapy regimens of 4 or 5 days, the use of rescue medication was higher with transdermal ... See full document

... compared with aprepitant. All patients received the same triple combination of palonosetron, dexamethasone, and aprepitant administered on day 1 for prophylaxis of acute CINV. This superiority trial did not meet its ... See full document

... the use of palonosetron alone for CINV prevention (Tables 3 and ...the use of other antiemetics was prohib- ...emetogenic chemotherapy (LEC), ... See full document

... with alcohol, sedatives, hypnotics, or other psychoactive substances due to the potential for augmentation of CNS effects. Nabilone should be used with caution in patients with current or past history of psychiatric ... See full document

... “chemotherapy induced nausea and vomiting” in combination with “highly emetogenic chemotherapy” and “randomized controlled clinical trials” to identify studies related to ... See full document

... cancer chemotherapy are nausea and ...the use of 5-HT 3 antagonists as a pharmacological intervention for acute and delayed nausea and vomiting for moderately and highly emetogenic ... See full document

... in prevention of ...Preventing chemotherapy-induced nausea and vomiting with netupitant/ palonosetron,the fi rst fi xed combination antiemetic: current and future ... See full document

... Abstract: Prevention of nausea and vomiting is the main goal of antiemetic treatment in cancer patients scheduled to receive ...before chemotherapy and patients should be protected for up to ... See full document

... Abstract: Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant deterioration in quality of ...repeated chemotherapy cycles, and patient characteristics ... See full document

... the use of olanzapine for five days could result in the improvement of QoL because of its antipsychotic effects, which need to further study for no relevant studies to be ...delayed nausea and ... See full document

... for prevention of CINV in moderately and highly emetogenic ...emetogenic chemotherapy assessed the efficacy of dexamethasone as prophylaxis for ...(no vomiting or retching) for both acute (odds ... See full document

... of chemotherapy administration), delayed (observed from the second day post chemotherapy administration and may persist for 5 - 7 days) or anticipatory (observed before chemotherapy ...during ... See full document

... of chemotherapy administration for acute CINV, and either treatment other than a corticosteroid or unspecified antiemetic treatment for delayed CINV (Holdsworth & Vo-Nguyen ...received chemotherapy, ... See full document

... maximum nausea 25 mm on a 100 mm VAS); complete response at best (no emesis, no rescue therapy, maximum nausea 25 mm on a 100 mm VAS); and incomplete response (complement of the preced- ing states: some ... See full document

... the prevention of delayed CINV, it is not much in use now because of its low therapeutic index and its use is generally reserved for agents with low emetogenic potential or in patients intolerant or ... See full document

... Remarks: The panel recognizes that the evidence base for these agents in adult patients consists of older studies that were not conducted in the context of currently recommended CINV prophylaxis and is of low quality. ... See full document

... Chemotherapy-induced nausea and vomiting (CINV) are distressing side effects of ...the use of aprepitant (APR) and casopitant (CAS) in breast cancer patients receiving AC-type ... See full document

... of chemotherapy- induced nausea and vomiting (CINV), in combination with serotonin type 3 receptor antago- nists and ...concomitant use of CYP3A4 inhibitors, but in contrast to ... See full document

... Abstract: Prevention of chemotherapy-induced nausea and vomiting (CINV) is a key component of treatment for patients with ...multiple-day chemotherapy, in whom CINV was managed ... See full document

... for use in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeated courses of emetogenic cancer ... See full document